Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.

Front Immunol · 2025 · PMC11876378 · PMID 40040701

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

In parallel, we reported a trend in the reduction of IFN-γ + CD107a + CD8 + T cell responses specific to the Omicron spike but did not reach statistical significance ( P = 0.06), even if the number of patients with detectable IFN-γ + CD107a + CD8 + T cell responses to the Omicron spike decreased from 8 out of 9 at 16 weeks to 3 out of 9 at 26 weeks ( Figure 3D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.